Phase

A headshot of David Grabowski

Measurement of patient function is a major barrier to creating fair compensation after the acute phase

As a congressional advisory board debates how to consolidate all post-acute care providers under a single payment system, the use of self-reported data continues to raise doubts about the ability to accurately measure patient outcomes. Members of the Medicare Payments Advisory Commission on Thursday asked staff to continue evaluating a proposed prospective payment system with …

Measurement of patient function is a major barrier to creating fair compensation after the acute phase Read More »

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis

SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc. today announced positive interim clinical results from an ongoing Phase 2 study of its lead clinical development candidate, pegsitacianine, for the detection of residual disease after cytoreductive surgery. (CRS). Study results were presented by Patrick Wagner, MD, Department of Surgical Oncology, Allegheny Health Network Cancer Institute, during an oral presentation …

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis Read More »

Mental wellness and alcohol moderation will drive next phase of functional beverage growth, Recess CEO predicts

Mental wellness and alcohol moderation will drive next phase of functional beverage growth, Recess CEO predicts

Breaklaunched in 2018 with CBD-infused drinks​,​ and says he remains “the undisputed category leader in CBD beverageswith distribution in CBD-friendly states across the country. However, founder and CEO Ben Witte has made it clear from the start that he is “build a brand, not market an ingredient,​​”and say it Recess Mood line without CBD – …

Mental wellness and alcohol moderation will drive next phase of functional beverage growth, Recess CEO predicts Read More »

Mental wellness and alcohol moderation will drive next phase of functional beverage growth, Recess CEO predicts

Mental wellness and alcohol moderation will drive next phase of functional beverage growth, Recess CEO predicts

Breaklaunched in 2018 with CBD-infused drinks​,​ and says he remains “the undisputed category leader in CBD beverageswith distribution in CBD-friendly states across the country. However, founder and CEO Ben Witte has made it clear from the start that he is “build a brand, not market an ingredient,​​”and say it Recess Mood line without CBD – …

Mental wellness and alcohol moderation will drive next phase of functional beverage growth, Recess CEO predicts Read More »

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab

The ROSALIA study met the primary endpoints, confirming that the proposed biosimilar denosumab matches the reference product in terms of pharmacokinetics, pharmacodynamics, efficacy, safety and immunogenicity in postmenopausal women with osteoporosis Osteoporosis is responsible for 8.9 million bone fractures a year, including debilitating hip fractures – a number that is expected to rise dramatically over …

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab Read More »